From Financialisation to Innovation in UK Big Pharma
- 116pagine
- 5 ore di lettura
This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.